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Abstract
Background: In the work of Chari et al. entitled "Effect of active smoking on the human bronchial
epithelium transcriptome" the authors use SAGE to identify candidate gene expression changes in
bronchial brushings from never, former, and current smokers. These gene expression changes are
categorized into those that are reversible or irreversible upon smoking cessation. A subset of these
identified genes is validated on an independent cohort using RT-PCR. The authors conclude that
their results support the notion of gene expression changes in the lungs of smokers which persist
even after an individual has quit.
Results: This correspondence raises questions about the validity of the approach used by the
authors to analyze their data. The majority of the reported results suffer deficiencies due to the
methods used. The most fundamental of these are explained in detail: biases introduced during data
processing, lack of correction for multiple testing, and an incorrect use of clustering for gene
discovery. A randomly generated "null" dataset is used to show the consequences of these
shortcomings.
Conclusion: Most of Chari et al.'s findings are consistent with what would be expected by chance
alone. Although there is clear evidence of reversible changes in gene expression, the majority of
those identified appear to be false positives. However, contrary to the authors' claims, no
irreversible changes were identified. There is a broad consensus that genetic change due to
smoking persists once an individual has quit smoking; unfortunately, this study lacks sufficient
scientific rigour to support or refute this hypothesis or identify any specific candidate genes. The
pitfalls of large-scale analysis, as exemplified here, may not be unique to Chari et al.
Background
I read with interest the recent work, published in BMC
Genomics, entitled "Effect of active smoking on the human
bronchial epithelium transcriptome" [1]. In this article,
the authors present an analysis of gene expression profiles
generated using serial analysis of gene expression (SAGE)
[2]. The profiles were obtained from samples of the lung
epithelium taken from individuals who have never
smoked, had quit smoking, or are current smokers. The
authors highlight the differences in gene expression
between the three groups, with a particular focus on a sub-
stantial number of changes that appear to persist after an
individual has stopped smoking. These results are intrigu-
ing, as they suggest that some etiology is permanently
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maintained after smoking cessation, that this manifests
itself at the level of gene expression, and that such changes
may contribute to an increased risk of developing lung
cancer. The findings were widely reported in the main-
stream media [3,4]. However, I have serious concerns
about the statistical methods the authors employed and,
consequently, the validity of the conclusions drawn.
Main criticisms
My critique follows the order of results presented in the
original paper. A summary of the issues addressed in this
correspondence and their consequences are given in Table
1. In many cases, the authors draw inferences from their
analysis that can be explained by chance alone. To dem-
onstrate this, I created a null (or random) dataset that
could be analyzed with the approaches used in Chari et al.
This "null" dataset was generated by combining the SAGE
data from all 24 of their analyzed samples and then ran-
domly re-distributing this "meta-transcriptome" into
libraries with sizes equal to those in the original dataset.
The organization of these virtual libraries into never,
former, and current smoker sub-categories is identical to
the original dataset. Thus, the reference dataset retains the
effects introduced by having unequal library sizes, une-
qual group sizes, and a range of total signal for each tag.
The most important feature of the null dataset is that any
correlations of tag expression values with smoking status have
occurred by chance alone.
The relationship between the transcriptomes of never, 
former, and current smokers
Chari et al. show the gross relationship between sample
types in terms of the number of tags preferentially
expressed in different subsets of the three smoking status
groups (never, former, and current smokers). This is often
seen in published SAGE studies, and it serves to orient the
Table 1: Summary of criticisms.
Flaw Consequence
poor definition of "preferential" expression introduces unchecked bias from different group sizes
incorrect use of Venn diagram confounds overall sense of group-specific differences
use of raw tag counts to determine "preferential" expression introduces unchecked bias from different library sizes
data filtered using criteria that includes variable to be tested pre-selects for data more likely to be found significant, confounding 
estimated of false discovery rate (FDR)
significance threshold set to p ≤ 0.05 without adjusting for multiple 
testing
false discovery rate (FDR) could be very high
"significant" results undergo post hoc fold-change filter low tag counts more likely to pass the filter, yet these more likely to 
represent random variation
other possible null hypotheses not tested not possible to check for consistency with known biology
null hypotheses formed with 2 of the 3 sample types loss of power
data selected for differential expression is clustered formation of distinct clusters is meaningless
genes tested for consistency with third sample group restricted to genes 
pre-selected as different between original two groups
flaws in implementation of first hypothesis test become propagated and 
amplified in second hypothesis test
no RT-PCR of irreversible genes no validation of irreversible gene expression hypothesis
evidence for GSK3B as an irreversible gene is weak or supports 
reversible hypothesis
selection of GSK3B for further experimentation is not indicated
tags per million (TPM) used in statistical testing rather than for reporting 
purposes only
artificially inflates non-zero counts
some SAGE tags incorrectly mapped a) follow-up RT-PCR is not validation, b) evidence for involvement of 
COX2 pathway is weaker than implied
A short description of each of the criticisms addressed in this correspondence, and their consequences for Chari et al.BMC Genomics 2009, 10:82 http://www.biomedcentral.com/1471-2164/10/82
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reader to the data and provide a preliminary sense of
group-specific differences. A Venn diagram, like that
found in Chari et al., is a popular way of visualizing the
results. However, there are two concerns with the authors'
particular application of this method.
First, the criterion for "preferential" expression is uncon-
ventional. Specifically, they state "the criteria chosen for
preferential expression was a threshold of a raw tag count of ≥
2 across all samples in a particular set, but not existing in the
other sets". This would seem to imply that a tag is preferen-
tially expressed if it appears at the given threshold in all of
the libraries of one group, and is below the threshold in
all of the libraries of the other two groups. However, an
inspection of the authors' supplementary material reveals
that "not existing in other sets" can mean that a raw tag
count of 0 or 1 appears in any library in both of the com-
peting groups. For example, tag CGGTTTGCAT is consid-
ered preferentially expressed in former smokers and has
the following counts: current = (1, 16, 12, 5, 17, 14, 16,
8), former = (19, 11, 8, 11, 2, 8, 5, 7, 6, 8, 3, 11), and never
= (15, 0, 11, 11). However, the average expression in each
group is: current = 100.7 TPM, former = 59.9 TPM, and
never = 67.6 TPM. This problem is quite pronounced for
a significant fraction of tags preferentially expressed in
each of the never, former, and current smoker groups: 57/
227 (25%), 33/102 (32%), and 635/2013 (32%), respec-
tively, actually have a higher mean expression in one or
both of the competing groups!
Second, even if the above approach was valid, there are
severe biases introduced as a result of unequal library and
group sizes. The former bias is exacerbated because the
authors utilize raw tag counts in their comparisons. This
means that a tag count of 2 from a library of 50,000 tags
is equivalent to a tag count of 2 from a library of 200,000
tags. In the latter, the exclusion criterion (a 0 or 1 in at
least one library) is more easily met for groups that have
more libraries. I applied the same procedure to the "null"
dataset, and the resulting diagram shows similar values to
those obtained from the real data (Figure 1). In particular,
the small number of never smoker libraries results in a
large estimate of the "preferentially" expressed never
smoker tags.
For these reasons, the results reported by the authors are
of little use in determining a relationship between never,
current and former smoker transcriptomes. An alternative
would be to use much higher expression thresholds that
apply equally to all libraries within a group to reduce the
effects of sampling variation and differences in library and
group sizes (e.g. ≥50 TPM versus ≤10 TPM). Principal
component analysis or hierarchical clustering of the data
are also good alternatives to visualize the overall relation-
ship between profiles.
Multiple testing and the determination of differentially 
expressed tags
In a review of microarray studies used to explore cancer
outcomes, Dupuy and Simon identified the failure to ade-
"Venn" diagram using Chari et al. methodology on the null and the actual dataset Figure 1
"Venn" diagram using Chari et al. methodology on the null and the actual dataset. The left hand Venn diagram 
shows values obtained using a null (randomized) dataset, and the right hand Venn diagrams shows values obtained using the 
actual dataset. Note these do not represent properly formed Venn diagrams (see text for details).
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quately control for false positives as a result of multiple
testing as the "most common and serious" flaw they
observed in procedures for gene selection [5]. The prob-
lem can be grasped intuitively when considering a
hypothesis test of 10,000 genes (or, in this case, tags). If
one considers a p-value ≤ 0.05 as being significant, then
we expect that 500 genes will be identified by chance
alone. If 1500 genes are subsequently identified from the
actual data, we can estimate that 500/1500 = 33% of these
will be false positives. That this problem remains an issue
in published studies is truly unfortunate, since a range of
methods are available to overcome this problem. For
instance, a simple Bonferroni correction or the Benjamini-
Hochberg method are widely accepted and commonly
used [6,7]. These methods can provide corrected p-values
or estimates of the false discovery rate (FDR) for a given
threshold  p-value. Moreover, powerful resampling
approaches (like that used to estimate the FDR in this cor-
respondence) are precise and increasingly common with
the rise in available computing power. Regardless of the
method used, the objective is to determine a statistical cut-
off that results in a reasonable number of false positives.
An acceptable adjusted p-value or FDR is somewhat arbi-
trary, but for the latter metric a value lower than 10–20%
is commonly cited [5].
In Chari et al., the authors' failure to account for multiple
testing or to provide some estimate of the FDR drastically
diminishes the value of their findings. The authors use a
Mann-Whitney U statistic (a non-parametric test) on each
tag to calculate the p-value for the null hypothesis that
never smokers are the same as current smokers. The
authors restrict their testing to tags with a "mean tag count
of ≥20 tags per million (TPM) in at least one of never,
former or current smoker SAGE libraries". This introduces
a bias by pre-selecting tags for testing based on criteria that
includes the variable being tested (in this case, smoking
status). This bias could be reasonably addressed by filter-
ing using a criterion of a mean expression of 20 TPM
across all libraries.
In any event, this filter produces a reduced test set of 8,148
tags to which the statistic is applied. The authors select
those tags with p ≤ 0.05 and then apply a fold-change cri-
terion of ≥2. Before more fully exploring the central issue
of multiple testing, it should be briefly mentioned that the
fold-change criteria is somewhat dubious. It is easier for
tags with low counts to meet this threshold than for those
with higher counts. For example, assuming libraries con-
sisting of 100,000 tags, a count of 1 versus a count of 3
represents a 3-fold change (p = 0.62, χ2-test), while the
more significant difference of a count of 50 versus a count
of 75 represents only a 1.5-fold change (p = 0.032, χ2-
test). This is a concern when using a non-parametric test
like the Mann-Whitney U with SAGE, since the relative
rank of expression rather than the actual difference is used
to provide statistical inference.
To demonstrate the larger problem of multiple testing, I
compared the number of tags that meet a given threshold
p-value in the actual dataset against the average number
obtained from the null dataset in order to estimate the
FDR. One must also use the number of results found prior
to the use of a post hoc filter like fold-change, and I do so
here. It's not clear from Chari et al. whether all 8,148 tags
or a smaller number representing a minimum of 20 TPM
in only the never or current smoker groups were used. In
my estimates of the FDR, I use the more generous assump-
tion of the latter (7,764 tags). Of these, 885 tags have p ≤
0.05 and 609 of these pass the fold-change filter. When
this identical analysis is applied to the null dataset, 7,406
tags are expressed at a mean of 20 TPM in either the never
or current smoker groups. Of these, 418 tags have p ≤ 0.05
and 195 of these pass the fold-change filter. Therefore, we
can estimate the FDR as 418/885 = 47.2%. This means
that, at a minimum, nearly half of the authors' findings
are false positives. The true FDR will be higher due to the
initial biased filter of group-specific expression of ≥20
TPM and still higher in the reduced set of 609 tags because
of the bias introduced by the fold-change filter.
It is unfortunate that the authors only reported the find-
ings of a test of one null hypothesis (N = C). The other
null hypotheses of (N = F) and (F = C) were not discussed.
When performing these comparisons using the real and
null dataset, a disturbing trend emerges (Table 2). Specif-
ically, the estimated FDR is fairly similar amongst all three
of the possible comparisons at p ≤ 0.05 (47.2%, 50.2%,
and 46.5%). This would suggest that there are a similar
number of tags with differential expression specific to
each of the three groups. This presents a problem, since
the authors' hypothesis of "reversible" and "irreversible"
gene expression change would lead one to expect that
never and current smokers would define the limits of
expression, with former smokers falling somewhere
within this continuum. In order to explore this further, I
plotted the estimated FDR over a range of cutoff p-values
to see if a clearer pattern would emerge with more strin-
gent criteria (Figure 2). It can be clearly seen that as one
approaches a more rigorous p-value cutoff, the FDR falls
below 20% for both the N = C and F = C null hypotheses,
but remains at around 40% for the N = F null hypothesis.
One must keep in mind that the number of samples in
each group will affect the limits of confidence that can be
obtained in their corresponding hypothesis test, but it
seems clear that the current smoker group is similarly dif-
ferent from either never or former smokers. This can be
explored more directly by formulating null hypotheses
based on all of the groups. Indeed, this seems to be the
most natural way of identifying "reversible" and "irrevers-BMC Genomics 2009, 10:82 http://www.biomedcentral.com/1471-2164/10/82
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ible" gene expression differences. Three null hypotheses
are possible: (N, F = C), (N = F, C), (N, C = F). The first
two would correspond to "reversible" and "irreversible"
changes, respectively, while the third does not correspond
with the expected biology of smoke-exposure and could
act as an internal control (i.e. this comparison would be
expected to produce comparatively fewer results than the
other two). When I performed this analysis using the
authors' methods, the concerns alluded to in the two-
group comparisons become all too clear (Table 2). The
only null hypothesis where a correction for multiple test-
ing can yield a FDR ≤20% is (N, F = C), which corresponds
to "reversible" changes. (N = F, C), which corresponds to
"irreversible" changes, has an abysmal FDR once a cutoff
of about p  ≤ 0.01 is established (Figure 3). Even the
hypothesis test for genes specific to former smokers, (N, C
= F), performs better.
There do appear to be changes that correlate with the indi-
vidual  groups, since the estimated FDR is well below
100%. However, the differences are clearly difficult to dis-
tinguish from random variation in the dataset and most
certainly do not support the irreversible/reversible dichot-
omy imposed by the authors. Most likely, there are other
explanatory variables that would better explain the struc-
ture of the data. If such covariates were even weakly corre-
lated with smoking status, they may well produce the
results shown in this correspondence. In fact, several
enticing variables are listed in the authors' own sample
descriptions: age, pack-years, lung function, and years
since quitting.
Supervised clustering of never, former, and current smoker 
profiles
Chari et al. use a technique they refer to as "supervised
clustering". Dupuy and Simon describe this approach as
the "most common and serious flaw" when performing
class discovery [5]. Specifically, one cannot state that clus-
ters corresponding with a variable (i.e. smoking status)
are meaningful if the input genes were selected for a cor-
relation with the same variable. In Chari et al., the authors
cluster the 609 tags selected based on their differential
expression between never and current smokers. Since the
tags were selected based on this very property, it is not sur-
prising that distinct clusters emerge; however, these clus-
ters are not meaningful.
The authors go a step further by adding the expression
data for the former smokers and then claiming that the
clustering of all three is meaningful (authors' Figure 2A). If
one was to generate random data for three equal-sized
groups, select genes that are the most differentially
expressed between two of these groups, and then proceed
to cluster the data for all three, one would expect a similar
Estimated false discovery rate at different threshold p-values for comparisons of two groups Figure 2
Estimated false discovery rate at different threshold p-values for comparisons of two groups. The x-axis repre-
sents different p-value cutoffs (0.00–0.10) to determine differential expression, and the y-axis represents the estimated false 
discovery rate (FDR) expected for each cutoff. The color key to differentiate the three possible null hypotheses comprising 
two of the three groups is shown in the legend.
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pattern to that observed by the authors to emerge. How-
ever, in this case, the dataset has unequal library and
group sizes and so the null clustering pattern will be
affected. I was unable to reproduce the exact hierarchical
clustering pattern in Chari et al. for their 609 differentially
expressed tags, despite using the Genesis software to per-
form a single-link clustering with Euclidean distance (as
described in the paper) [8]. After exhaustive trials using
different program options, it was found that row normal-
ization of the data followed by single-link clustering with
a Pearson correlation distance metric yielded the most
similar results. When I clustered the 195 tags from a rep-
resentative resampling in the null dataset that were differ-
entially expressed between never and current smokers,
two distinct clusters emerged (Figure 4). The never smok-
ers clustered tightly together, whereas the current and
former smokers formed a distinct, but more diffuse, clus-
ter. The clustering pattern observed for the authors' real
data actually argues that former smokers are more similar
to never smokers than expected by chance. Specifically, in
contrast to the null clustering pattern, the former smoker
libraries are distinct from current smokers and are more
similar to the never smoker cluster.
For these reasons, this section of the authors' results is
almost meaningless. The little inference that can be made
Estimated false discovery rate at different threshold p-values for comparisons of three groups Figure 3
Estimated false discovery rate at different threshold p-values for comparisons of three groups. The x-axis repre-
sents different p-value cutoffs (0.00–0.10) to determine differential expression, and the y-axis represents the estimated false 
discovery rate (FDR) expected for each cutoff. The color key to differentiate the three possible null hypotheses involving pair-
wise combinations of all of the three groups is shown in the legend.
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Table 2: Estimated false discovery rate (FDR) of null hypotheses using different combinations of the three groups
null dataset actual dataset
null hypothesis ≥20 TPM p ≤ 0.05 fold-change ≥ 2 ≥20 TPM p ≤ 0.05 fold-change ≥ 2F D R
N = C 7406 418 195 7764 885 609 47.2
N = F 7323 384 157 7547 765 447 50.2
F = C 7102 416 92 7318 895 433 46.5
(N, F) = C 7726 411 82 8148 959 460 42.8
N = (F, C) 7726 382 67 8148 836 475 45.7
(N, C) = F 7726 388 157 8148 818 314 47.4
The estimated false discovery rate (FDR) of different null hypotheses when grouping the 24 SAGE libraries of Chari et al. into never, former, and 
current smokers. A p-value cutoff of 0.05 was used, as in the original paper.BMC Genomics 2009, 10:82 http://www.biomedcentral.com/1471-2164/10/82
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actually indicates a situation at odds with the authors'
stated conclusions. Hierarchical clustering and principal
component analysis are powerful techniques in class dis-
covery and, as alluded to previously, would have been bet-
ter applied at the beginning of the authors' paper in an
unsupervised manner on an unbiased set of data that does
not consider smoking status.
Additional criticisms
Although the key concerns have been described above, a
number of additional issues with the authors' selection of
irreversible and reversible genes, as well as the RT-PCR
validation efforts, were removed for brevity. These have
been included as a supplementary document (see Addi-
tional File 1).
Hierarchical clustering using Chari et al. methodology on the null and the actual dataset Figure 4
Hierarchical clustering using Chari et al. methodology on the null and the actual dataset. Counts for SAGE tags 
that met a threshold p-value cutoff of 0.05 for the null hypothesis of never = current smokers. The counts were row normal-
ized and underwent single-link hierarchical clustering using a Pearson correlation as a distance metric. The left-hand tree rep-
resents the actual dataset and the right-hand tree represents the null dataset.BMC Genomics 2009, 10:82 http://www.biomedcentral.com/1471-2164/10/82
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Conclusion
Large-scale data analysis is not trivial and flaws are often
found in the published literature. It is unfortunate that
this perceived complexity and unreliability of large data
set analyses have caused many to be wary of gene expres-
sion studies when they hold so much potential to provide
new insights. Many of the pitfalls of a large-scale analysis
can be avoided by keeping a few basic tenets in mind. The
data as presented supports the idea that changes to gene
expression occur as a result of active smoking, but pro-
vides no compelling evidence that these changes persist
once an individual has quit. Given that this study was
widely publicized, these critical shortcomings become
even more important to communicate. This is not to say
that such permanent changes do not exist, or that such
changes are not identifiable from the dataset the authors
use. However, my perspective is that Chari et al. requires
major revisions to support their stated conclusions or to
consider the work as a basis for decision making in the
design of future research.
Authors' contributions
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Response from original authors
Raj Chari, Raymond T. Ng
Email: rchari@bccrc.ca
The analysis of high throughput gene expression data has
been a challenging endeavor in the field of genomics.
Numerous techniques and approaches have been devel-
oped and utilized, with each method having its own
advantages and disadvantages. In an extensive analysis of
the statistical approaches used in our original study [1],
Zuyderduyn claimed to have derived different conclu-
sions. Specifically, the existence of genes irreversibly
expressed upon smoking cessation.
With respect to the statistical analysis, two of the main
criticisms raised were the lack of using a multiple hypoth-
esis testing correction and the use of the Venn diagram in
one of our display items. The purpose of using a multiple
hypothesis testing correction is to reduce potential false
positives and Zuyderduyn demonstrates by randomly per-
muting the dataset, there would be a high degree of false
positives at the statistical thresholds we employed. Given
that there have only been a handful of studies to date
examining gene expression changes associated with smok-
ing in the bronchial epithelium, it is difficult to ascertain
whether these false positives are indeed false positives.
Those changes which corroborate between studies tend to
agree with those which we have place the most confi-
dence. In a study by Beane et al published after ours [9],
where the issue of reversibility and irreversibility is inves-
tigated at a greater detail, we see a large number of genes
which we identified in our study which were also identi-
fied in this study. In addition, it is important to emphasize
that the genes which did not corroborate between both
studies are not necessarily false positives, as subtler
changes identified using one methodology may not
always be readily detected by another. In terms of the
Venn diagram, it was a simple illustration of genes
expressed at different levels among different groups. Sim-
ilar graphics were used by Shah et al to illustrate expres-
sion changes in current, former and never smokers in a
previously published study [10]. This is a succinct way to
summarize data.
There was also an issue of calling GSK3B as an irreversible
gene. In a study by Spira et al [11], a gene with irreversible
expression was defined as a gene whose expression was
different between current and never smokers, but also dif-
ferent between former and never smokers. In our study,
we illustrate the relationship between genes such as
CABYR, GSK3B, COX2, TFF3, and MUC5AC and we show
that the expression of three of the genes appeared to be
significantly different between current and never smokers.
Though COX2 expression was not evident, we observed
an interesting trend of GSK3B expression. Subsequently,
using a more precise experimental method, namely quan-
titative PCR, we assessed its expression in a second cohort
with a larger panel of never smokers. We found that there
was a statistically significant change in GSK3B expression
between current and never smokers as well as former and
never smokers. Hence, by the definition used above, this
would qualify this gene as irreversible. It is important to
reiterate that the key genes discussed in the paper such as
CABYR,  TFF3,  MUC5AC, and GSK3B  were not only
assessed using SAGE, but were also assessed using quanti-
tative PCR in a completely different cohort of samples.
In conclusion, though criticisms raised by Zuyderduyn are
constructive and may serve as a cautionary note for gene
expression data analysis in general, we firmly believe in
the conclusions we have reached which were further sup-
ported by experimental evidence subsequently reported
by other groups. Moreover, as with all large scale gene
expression studies, it is useful to remember that genes
identified at the first level of statistical analysis are in fact
"best guesses". Further experimental verification is typi-
cally necessary to elucidate the relevance of the candidate
genes to the disease state studied.Publish with BioMed Central    and   every 
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